Literature DB >> 811124

Protein synthesis in vitro by cryopreserved Plasmodium falciparum.

C Diggs, K Joseph, B Flemmings, R Snodgrass, F Hines.   

Abstract

Plasmodium falciparum-parasitized erythrocytes obtained from infected owl monkeys (Aotus trivirgatus) and stored in the frozen state retain both the capacity to incorporate 14C isoleucine into protein and to infect animals. The cryopreservation method involves the use of glycerol and the reconstitution of isotonicity after thawing. Animals have been infected from material held for up to 273 days and protein synthesis has been demonstrated in vitro for up to 180 days after freezing. The specificity of protein synthesis as an activity of the parasites was shown by the inactivity of control uninfected erythrocytes stored by the same method. Additional evidence for the specificity of the reaction was obtained from inhibition studies with chloroquine; a 7 X 10(-5) M concentration of the drug resulted in 50% inhibition of the initial rate of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811124     DOI: 10.4269/ajtmh.1975.24.760

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Antibodies and DNA probes used to analyze variant populations of the Indochina-1 strain of Plasmodium falciparum.

Authors:  M Hommel; M Hughes; P Bond; J M Crampton
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

2.  Survival of Aegyptianella pullorum, Anaplasma marginale and various parasitic protozoa following prolonged storage in liquid nitrogen.

Authors:  W Raether; H Seidenath
Journal:  Z Parasitenkd       Date:  1977-08-25

3.  Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture.

Authors:  Céline Borlon; Bruce Russell; Kanlaya Sriprawat; Rossarin Suwanarusk; Annette Erhart; Laurent Renia; François Nosten; Umberto D'Alessandro
Journal:  Int J Parasitol       Date:  2011-12-27       Impact factor: 3.981

4.  Analysis of macrophage interactions with cryopreserved amastigotes of Leishmania tropica.

Authors:  D L Hoover; C A Nacy
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

5.  Plasmodium falciparum malaria. An amelanotic melanoma cell line bears receptors for the knob ligand on infected erythrocytes.

Authors:  J A Schmidt; I J Udeinya; J H Leech; R J Hay; M Aikawa; J Barnwell; I Green; L H Miller
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

6.  Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.

Authors:  Benoit Witkowski; Nimol Khim; Pheaktra Chim; Saorin Kim; Sopheakvatey Ke; Nimol Kloeung; Sophy Chy; Socheat Duong; Rithea Leang; Pascal Ringwald; Arjen M Dondorp; Rupam Tripura; Françoise Benoit-Vical; Antoine Berry; Olivier Gorgette; Frédéric Ariey; Jean-Christophe Barale; Odile Mercereau-Puijalon; Didier Menard
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

7.  Intravenous immunoglobulin in the treatment of paediatric cerebral malaria.

Authors:  T E Taylor; M E Molyneux; J J Wirima; A Borgstein; J D Goldring; M Hommel
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

8.  Plasmodium falciparum: inhibition/reversal of cytoadherence of Thai isolates to melanoma cells by local immune sera.

Authors:  B Singh; M Ho; S Looareesuwan; E Mathai; D A Warrell; M Hommel
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  Transplacentally transferred functional antibodies against Plasmodium falciparum decrease with age.

Authors:  Patrick T Wilson; Indu Malhotra; Peter Mungai; Christopher L King; Arlene E Dent
Journal:  Acta Trop       Date:  2013-07-30       Impact factor: 3.112

10.  Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes.

Authors:  P H David; M Hommel; L H Miller; I J Udeinya; L D Oligino
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.